Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Alireza, Biglari"'
Autor:
Delaram Doroud, Mona Sadat Larijani, Alireza Biglari, Fatemeh Ashrafian, Talieh Sabouni, Sana Eybpoosh, Vicente Verez-Bencomo, Yury Valdés-Balbín, Dagmar García-Rivera, Yaneli Herrera-Rojas, Yanet Climent-Ruiz, Darielys Santana-Mederos, Amitis Ramezani
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract During COVID-19 pandemic, international pharmaceutical companies put effort to build global manufacturing networks for vaccines. Soberana Plus vaccine, a recombinant protein based vaccine (RBD dimer), with the trade name of PastoCovac Plus i
Externí odkaz:
https://doaj.org/article/ad6a9e1b41334add9fc1681433e0005c
Autor:
Hamed Hesami, Serwa Ghasemi, Golnaz Houshmand, Yalda Nilipour, Mahshid Hesami, Alireza Biglari, Shahriar Nafissi, Majid Maleki, Samira Kalayinia
Publikováno v:
BMC Musculoskeletal Disorders, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Limb girdle muscular dystrophies (LGMDs) constitute a heterogeneous group of neuromuscular disorders with a very variable clinical presentation and overlapping traits. The clinical symptoms of LGMD typically appear in adolescence
Externí odkaz:
https://doaj.org/article/8f548777472647cfb5bf30df13f1a719
Autor:
Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan, Elham Bayat, Alireza Biglari, Mohammad Ali Shokrgozar, Reza Ahangari Cohan, Esmat Mirabzadeh, Soheila Ajdary, Mahdi Behdani
Publikováno v:
AMB Express, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The immunotherapeutic application of interleukin-2 (IL-2) in cancer treatment is limited by its off-target effects on different cell populations and insufficient activation of anti-tumor effector cells at the site of the tumor upon tolerated
Externí odkaz:
https://doaj.org/article/ef08f57dd2e34293b7ae0942d1f63137
Autor:
Amir Farjam Fazelifar, Maryam Pourirahim, Tannaz Masoumi, Alireza Biglari, Majid Maleki, Samira Kalayinia
Publikováno v:
Journal of Arrhythmia, Vol 39, Iss 3, Pp 430-453 (2023)
Abstract Background Long QT syndrome (LQTS) is a lethal cardiac condition. However, the clinical implementation of genetic testing has now made LQTS eminently treatable. Next‐generation sequencing has remarkable potential for both clinical diagnost
Externí odkaz:
https://doaj.org/article/967c83de6a274824939c2f14db09ac3c
Autor:
Amitis Ramezani, Rahim Sorouri, Saiedeh Haji Maghsoudi, Sarah Dahmardeh, Delaram Doroud, Mona Sadat Larijani, Sana Eybpoosh, Ehsan Mostafavi, Alireza Olyaeemanesh, Mostafa Salehi-Vaziri, Anahita Bavand, Ghazaleh Zarghani, Ladan Moradi, Fatemeh Ashrafian, Fahimeh Bagheri Amiri, Parisa Mashayekhi, Zahra Tahmasebi, Alireza Biglari
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The optimal booster vaccine schedule against COVID-19 is still being explored. The present study aimed at assessment of the immunogenicity and antibody persistency of inactivated-virus based vaccine, BBIP-CorV and protein-subunit based vacci
Externí odkaz:
https://doaj.org/article/8d9efc4af8e341c0b3b0fc6327053195
Autor:
Sana Eybpoosh, Alireza Biglari, Rahim Sorouri, Fatemeh Ashrafian, Mona Sadat Larijani, Vicente Verez-Bencomo, Maria Eugenia Toledo-Romani, Carmen Valenzuela Silva, Mostafa Salehi-Vaziri, Sarah Dahmardeh, Delaram Doroud, Mohammad Banifazl, Ehsan Mostafavi, Anahita Bavand, Amitis Ramezani
Publikováno v:
PLoS Pathogens, Vol 19, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/d6b736a9670c472fb9cd0b2aa605b7a8
Autor:
Behrokh Farahmand, Mona Sadat Larijani, Fatemeh Fotouhi, Alireza Biglari, Rahim Sorouri, Fahimeh Bagheri Amiri, Ali Eslamifar, Tahmineh Jalali, Mostafa Salehi-Vaziri, Mohammad Banifazl, Sarah Dahmardeh, Azita Eshratkhah Mohammadnejad, Anahita Bavand, Mahsa Tavakoli, Vicente Verez-Bencomo, Ehsan Mostafavi, Hassan Noori Daloii, Fatemeh Ashrafian, Masoumeh Saberpour, Amitis Ramezani
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20555- (2023)
COVID-19 pandemic has been managed through global vaccination programs. However, the antibody waning in various types of vaccines came to notice. Hereby, PastoCovac Plus as a protein subunit vaccine was investigated in immunized health care workers b
Externí odkaz:
https://doaj.org/article/648d691f633e440b90bb0a37d594a11f
Autor:
Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, Chaumey Rojas-Iriarte, Leyanis Céspedes-Henriquez, Misleidys Piedra-Bello, Dania Vega-Mendoza, Noelvia Pestana Pérez, Beatriz Paredes-Moreno, Meiby Rodríguez-González, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Laura Rodríguez-Noda, Rocmira Pérez-Nicado, Raul González-Mugica, Tays Hernández-García, Talía Fundora-Barrios, Martha Dubet Echevarría, Juliet María Enriquez-Puertas, Yenicet Infante-Hernández, Ariel Palenzuela-Díaz, Evelyn Gato-Orozco, Yanet Chappi-Estévez, Julio Cesar Francisco-Pérez, Miladi Suarez-Martinez, Ismavy C. Castillo-Quintana, Sonsire Fernandez-Castillo, Yanet Climent-Ruiz, Darielys Santana-Mederos, Yanelda García-Vega, María Eugenia Toledo-Romani, Delaram Doroud, Alireza Biglari, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo, María Elena Mesa-Herrera, Yarmila García-Cristiá, Leonor Verdecia-Sánchez, Rafael del Valle Rodríguez, Yudalvies Oquendo-de la Cruz, Daysi Álvarez-Montalvo, Randy Grillo-Fortún, Liset López-González, Omaida Fonte Galindo, Yeseni Reyes-González, Ana Beatriz González-Álvarez, Linet Gorrita-Mora, Rodrigo Valera-Fernández, Ivis Ontivero-Pino, Marisel Martínez-Pérez, Esperanza Caballero-Gonzalez, Aniurka Garcés-Hechavarría, Dayle Martínez-Bedoya, Maite Medina-Nápoles, Yeney Regla Domínguez-Pentón, Yadira Cazañas-Quintana, Thais Fundora Barrios, Diana R. Hernández Fernández, Gretchen Bergado-Báez, Ivette Orosa-Vazquez, Franciscary Pi-Estopiñan, Marianniz Díaz-Hernández, Otto Cruz-Sui, Enrique Noa-Romero, Arilia García-López, Sandra Rivadereira Muro, Gerardo Baro-Roman
Publikováno v:
International Journal of Infectious Diseases, Vol 126, Iss , Pp 164-173 (2023)
Objectives: To evaluate a heterologous vaccination scheme in children 3-18 years old (y/o) combining two SARS-CoV-2r- receptor binding domain (RBD)protein vaccines. Methods: A phase I/II open-label, adaptive, and multicenter trial evaluated the safet
Externí odkaz:
https://doaj.org/article/88ee0659b0bf4cf3888a8d4fcd8fc08e
Autor:
Maryam Barkhordar, Bahram Chahardouli, Alireza Biglari, Mohammad Ahmadvand, Tanaz Bahri, Farshid Alaeddini, Leyla Sharifi Aliabadi, Seied Saeid Noorani, Fahimeh Bagheri Amiri, Mohammad Biglari, Mohammad Reza Shemshadi, Ardeshir Ghavamzadeh, Mohammad Vaezi
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundAllogeneic hematopoietic stem cell transplant (allo-HSCT) recipients must be vaccinated against SARS-CoV-2 as quickly as possible after transplantation. The difficulty in obtaining recommended SARS-CoV-2 vaccines for allo-HSCT recipients mo
Externí odkaz:
https://doaj.org/article/8abdfd77b0084d4a871c12a2d5bb9b07
Autor:
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica Romero, Oscar Samón-Tabio, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Sonsire Fernández-Castillo, Yanet Climent-Ruiz, Yury Valdes-Balbín, Dagmar García-Rivera, Patrick Van der Stuyft, Vicente Verez-Bencomo
Publikováno v:
The Lancet Regional Health. Americas, Vol 18, Iss , Pp 100423- (2023)
Summary: Background: SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralising IgG and specific T-cell response. A third heterologou
Externí odkaz:
https://doaj.org/article/3dba4ee40a234d2ab6a8e682d6435a15